206 related articles for article (PubMed ID: 36321228)
1. The Antimicrobial Effect Against Multi-drug Resistant Bacteria of the SK4 Peptide: A Novel Hybrid Peptide of Cecropin-A and BMAP-27.
Masadeh MM; Laila SA; Haddad R; Alzoubi K; Alhaijaa AA; Alrabadi N
Curr Pharm Biotechnol; 2023; 24(8):1070-1078. PubMed ID: 36321228
[TBL] [Abstract][Full Text] [Related]
2. Functional and Toxicological Evaluation of MAA-41: A Novel Rationally Designed Antimicrobial Peptide Using Hybridization and Modification Methods from LL-37 and BMAP-28.
Masadeh M; Ayyad A; Haddad R; Alsaggar M; Alzoubi K; Alrabadi N
Curr Pharm Des; 2022; 28(26):2177-2188. PubMed ID: 35792128
[TBL] [Abstract][Full Text] [Related]
3. A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.
Almaaytah A; Farajallah A; Abualhaijaa A; Al-Balas Q
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004427
[TBL] [Abstract][Full Text] [Related]
4. Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.
Zheng Z; Tharmalingam N; Liu Q; Jayamani E; Kim W; Fuchs BB; Zhang R; Vilcinskas A; Mylonakis E
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483966
[TBL] [Abstract][Full Text] [Related]
5. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.
Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB
PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial efficacy of Cecropin A (1-7)- Melittin and Lactoferricin (17-30) against multi-drug resistant Salmonella Enteritidis.
Gourkhede DP; Bhoomika S; Pathak R; Yadav JP; Nishanth D; Vergis J; Malik SVS; Barbuddhe SB; Rawool DB
Microb Pathog; 2020 Oct; 147():104405. PubMed ID: 32707313
[TBL] [Abstract][Full Text] [Related]
7. Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption.
Rončević T; Gerdol M; Mardirossian M; Maleš M; Cvjetan S; Benincasa M; Maravić A; Gajski G; Krce L; Aviani I; Hrabar J; Trumbić Ž; Derks M; Pallavicini A; Weingarth M; Zoranić L; Tossi A; Mladineo I
Acta Biomater; 2022 Jul; 146():131-144. PubMed ID: 35470073
[TBL] [Abstract][Full Text] [Related]
8. A novel antimicrobial peptide YS12 isolated from Bacillus velezensis CBSYS12 exerts anti-biofilm properties against drug-resistant bacteria.
Suchi SA; Nam KB; Kim YK; Tarek H; Yoo JC
Bioprocess Biosyst Eng; 2023 Jun; 46(6):813-828. PubMed ID: 36997801
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum activity of membranolytic cationic macrocyclic peptides against multi-drug resistant bacteria and fungi.
Lohan S; Konshina AG; Tiwari RK; Efremov RG; Maslennikov I; Parang K
Eur J Pharm Sci; 2024 Jun; 197():106776. PubMed ID: 38663759
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
11. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
12. Design and characterization of a new hybrid peptide from LL-37 and BMAP-27.
Al Tall Y; Abualhaijaa A; Alsaggar M; Almaaytah A; Masadeh M; Alzoubi KH
Infect Drug Resist; 2019; 12():1035-1045. PubMed ID: 31118709
[No Abstract] [Full Text] [Related]
13. Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant
Chatupheeraphat C; Peamchai J; Luk-In S; Eiamphungporn W
Front Cell Infect Microbiol; 2023; 13():1153868. PubMed ID: 37113135
[TBL] [Abstract][Full Text] [Related]
14. Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.
Fox MA; Thwaite JE; Ulaeto DO; Atkins TP; Atkins HS
Peptides; 2012 Feb; 33(2):197-205. PubMed ID: 22289499
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of free or anchored antimicrobial peptides as candidates for the prevention of orthopaedic device-related infections.
D'Este F; Oro D; Boix-Lemonche G; Tossi A; Skerlavaj B
J Pept Sci; 2017 Oct; 23(10):777-789. PubMed ID: 28707817
[TBL] [Abstract][Full Text] [Related]
16. Functional Characterization of a Novel Hybrid Peptide with High Potency against Gram-negative Bacteria.
Tall YA; Al-Rawashdeh B; Abualhaijaa A; Almaaytah A; Masadeh M; Alzoubi KH
Curr Pharm Des; 2020; 26(3):376-385. PubMed ID: 32003660
[TBL] [Abstract][Full Text] [Related]
17. Development and Evaluation of the Efficacy and Toxicity of a New Hybrid Antimicrobial Peptide MY8.
Alrabadi N; Hamdan M; Haddad R; Sabi SH; Masadeh MM; Alzoubi KH; Al-Batayneh KM
Curr Pharm Des; 2023; 29(43):3488-3496. PubMed ID: 38083884
[TBL] [Abstract][Full Text] [Related]
18. Current synthetic chemistry towards cyclic antimicrobial peptides.
He T; Qu R; Zhang J
J Pept Sci; 2022 Jun; 28(6):e3387. PubMed ID: 34931393
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and antimicrobial activity of cecropin family in Hermetia illucens.
Peng J; Li L; Wan Y; Yang Y; An X; Yuan K; Qiu Z; Jiang Y; Guo G; Shen F; Liang G
Dev Comp Immunol; 2024 Mar; 152():105111. PubMed ID: 38081402
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
